Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| endothelial cell | 5 studies | 30% ± 13% | |
| fibroblast | 4 studies | 22% ± 9% | |
| oligodendrocyte | 4 studies | 23% ± 5% | |
| microglial cell | 3 studies | 20% ± 5% | |
| epithelial cell | 3 studies | 25% ± 11% | |
| smooth muscle cell | 3 studies | 19% ± 1% | |
| macrophage | 3 studies | 26% ± 10% | |
| goblet cell | 3 studies | 25% ± 7% | |
| pericyte | 3 studies | 37% ± 4% | |
| transit amplifying cell | 3 studies | 34% ± 16% | |
| astrocyte | 3 studies | 27% ± 8% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 4 studies | 27% ± 8% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| prostate | 100% | 919.13 | 245 / 245 | 100% | 4.83 | 502 / 502 |
| thymus | 100% | 992.17 | 653 / 653 | 100% | 5.30 | 603 / 605 |
| brain | 100% | 619.70 | 2632 / 2642 | 100% | 4.51 | 705 / 705 |
| breast | 100% | 707.54 | 459 / 459 | 98% | 5.08 | 1101 / 1118 |
| ovary | 100% | 1884.14 | 180 / 180 | 98% | 4.87 | 423 / 430 |
| adrenal gland | 100% | 1212.69 | 258 / 258 | 97% | 4.07 | 222 / 230 |
| kidney | 100% | 595.47 | 89 / 89 | 96% | 4.21 | 866 / 901 |
| lung | 100% | 819.66 | 578 / 578 | 95% | 3.79 | 1101 / 1155 |
| uterus | 100% | 988.96 | 170 / 170 | 95% | 3.52 | 434 / 459 |
| pancreas | 100% | 405.31 | 327 / 328 | 94% | 3.43 | 168 / 178 |
| bladder | 100% | 693.48 | 21 / 21 | 92% | 3.46 | 463 / 504 |
| stomach | 100% | 447.91 | 359 / 359 | 86% | 3.43 | 246 / 286 |
| intestine | 100% | 689.80 | 965 / 966 | 82% | 3.06 | 433 / 527 |
| esophagus | 100% | 541.46 | 1444 / 1445 | 82% | 3.29 | 150 / 183 |
| skin | 100% | 554.72 | 1801 / 1809 | 81% | 3.04 | 380 / 472 |
| liver | 100% | 366.00 | 226 / 226 | 60% | 1.51 | 245 / 406 |
| adipose | 100% | 619.81 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| spleen | 100% | 829.03 | 241 / 241 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 100% | 1.57 | 1 / 1 |
| blood vessel | 100% | 723.85 | 1334 / 1335 | 0% | 0 | 0 / 0 |
| heart | 98% | 403.20 | 846 / 861 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 93% | 4.75 | 27 / 29 |
| tonsil | 0% | 0 | 0 / 0 | 91% | 3.04 | 41 / 45 |
| muscle | 78% | 183.49 | 630 / 803 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 63% | 2.08 | 50 / 80 |
| peripheral blood | 59% | 411.40 | 549 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0006366 | Biological process | transcription by RNA polymerase II |
| GO_0035108 | Biological process | limb morphogenesis |
| GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
| GO_0006355 | Biological process | regulation of DNA-templated transcription |
| GO_0009653 | Biological process | anatomical structure morphogenesis |
| GO_0005634 | Cellular component | nucleus |
| GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
| GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
| GO_0046872 | Molecular function | metal ion binding |
| Gene name | ZNF141 |
| Protein name | Uncharacterized protein ZNF141 Zinc finger protein 141 |
| Synonyms | D4S90 hCG_34448 |
| Description | FUNCTION: May be involved in transcriptional regulation as a repressor. Plays a role in limb development. . |
| Accessions | Q4W5N2 D6RB60 ENST00000512994.5 D6RIY0 Q15928 ENST00000505939.5 ENST00000240499.8 |
